by John Finey | Nov 19, 2024 | Blog, MHRA, Windsor Framework
Given all the recent attention that has rightly been placed on the upcoming changes to medicinal products for the UK market, as a result of the implementation of parts of the Windsor Framework, it would be easy to assume that similar changes or at least thought processes would apply to other products.
by Natalie Harper | Oct 31, 2024 | Blog, MHRA, WDA(V)
In May 2024 the Veterinary Medicines Directorate (VMD) published and regarding the Veterinary Medicines Regulations 2013 (VMR). The Veterinary Medicines (Amendment etc.) Regulations 2024 are not effective but what does this mean for UK wholesalers?
by Steven Hewison | Aug 29, 2024 | Blog, MHRA, Windsor Framework
Unless they appear on the NIMAR list, PLGB licensed medicines are not licensed in Northern Ireland. That means they are effectively supplied to NI as an Unlicensed ‘Special’.
by Steven Hewison | Aug 28, 2024 | Blog, MHRA, Windsor Framework
After the implementation of the Windsor Framework, the Medicines and Healthcare products Regulatory Agency (MHRA) will license all medicines across the whole of the UK’.
by Steven Hewison | Aug 27, 2024 | Blog, MHRA, Windsor Framework
From the 1st of January 2025 the supply of medicines to Northern Ireland will be governed by the Windsor Framework, which will replace the Northern Ireland Protocol.
by Natalie Harper | Aug 8, 2024 | Blog, MHRA, WDA(H)
Management of change in your business should be a main cornerstone of any robust and functioning Quality Management System (QMS). The main advantages of having a strong change control process within your business include: